Overexpression of membrane glycoprotein PC-1 can influence insulin action at a post-receptor site

Journal of Cellular Biochemistry

Volumn 68, Issue 3, 1998, Pages 366-377

  Kumakura, Shinobu ^a   Maddux, Betty A ^a   Sung, Chin K ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Insulin action; Insulin receptor; Insulin resistance; PC 1; Tyrosine kinase

Indexed keywords

INSULIN RECEPTOR; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE;

AMINO ACID TRANSPORT; ARTICLE; AUTOPHOSPHORYLATION; CHINESE HAMSTER; ENZYME ACTIVATION; GENE OVEREXPRESSION; GLUCOSE TRANSPORT; IMMUNOBLOTTING; INSULIN BINDING; INSULIN RESISTANCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; CHO CELLS; CRICETINAE; GENE EXPRESSION; HUMANS; INSULIN; MEMBRANE GLYCOPROTEINS; PHOSPHORIC DIESTER HYDROLASES; PROTEIN-TYROSINE KINASES; PYROPHOSPHATASES; RECEPTOR, INSULIN; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION;

CRICETINAE; CRICETULUS GRISEUS;

EID: 0032032452     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19980301)68:3<366::AID-JCB7>3.0.CO;2-S     Document Type: Article

References (57)

1. Ausubel F, Brent R, Kingston R, Moore D, Seidman J, Smith J, Strahl K (1991): "Protein Expression: Current Protocols in Molecular Biology." New York: John Wiley & Sons, pp 16.01-16.20.16.
2. Baltensperger K, Kozma LM, Cherniack AD, Klarlund JK, Chawla A, Banerjee U, Czech MP (1993): Binding of the Ras activator Son of Sevenless to insulin receptor substrate-1 signaling complexes. Science 260:1950-1952.
3. Belfiore A, Costantino A, Fraser F, Pandini G, Mineo R, Vigneri P, Maddux B, Goldfine I, Vigneri R (1996): Over-expression of membrane glycoprotein PC-1 in MDA-MB231 breast cancer cells is associated with inhibition of insulin receptor tyrosine kinase activity. Mol Endocrinol 10:1318-1326.
4. Belli S, Goding J (1994): Biochemical characterization of human PC-1 an enzyme possessing alkaline phosphodiesterase I and nucleotide pyrophosphatase activities. Eur J Biochem 226:433-443.
5. Brunetti A, Maddux B, Wong K, Hofman C, Whittaker J, Sung C, Goldfine I (1989): Monoclonal antibodies to the human insulin receptor mimic a spectrum of biological effects in transfected 3T3/HIR fibroblasts without activating receptor kinase. Biochem Biophys Res Commun 165: 212-218
6. Carpenter CL, Auger KR, Chanudhuri M, Yoakim M, Schaffhausen B, Shoelson S, Cantley LC (1993): Phosphoinositide 3-kinase activated by phosphopeptides that bind to the SH2 domains fo the 85-kDa subunit. J Biol Chem 268:9478-9783.
7. Cheatham B, Vlahos CJ, Cheatham L, Wang L, Blenis J, Kahn CR (1994): Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol Cell Biol 14:4902-4911.
8. S6k activation mediated by phosphatidylinositol-3-OH kinase. Nature 370:71-75.
9. Czech M (1989): Signal transmission by the insulin-like growth factors. Cell 59:235-238.
10. Ellis L, Clauser E, Morgan D, Edery, Roth R, Rutter W (1986): Replacement of insulin receptor tyrosine residues 1162 and 1163 comprises insulin-stimulated kinase activity and uptake of 2-deoxyglucose. Cell 45:721-732.
11. Endemann G, Yonezawa K, Roth R (1990): Phosphatidylinositol kinase or an associated protein is a substrate for the insulin receptor tyrosine kinase. J. Biol Chem 265:396-400.
12. Forsayeth JR, Caro JF, Sinha MK, Maddux BA, Goldfine ID (1987a): Monoclonal antibodies to the human insulin receptor that activate glucose transport but not insulin receptor kinase activity. Proc Natl Acad Sci USA 84:3448-3451.
13. Forsayeth JR, Montemurro A, Maddux BA, DePirro K, Goldfine ID (1987b): Effect of monoclonal antibodies on human insulin receptor autophosphorylation, negative cooperativity, and down-regulation. J Biol Chem 262: 4134-4140.
14. Frittita L, Youngren J, Vigneri R, Maddux B, Trischitta V, Goldfine I (1996): PC-1 content in skeletal muscle of non-obese, non-diabetic subjects: Relationship to insulin receptor tyrosine kinase and whole body insulin sensitivity. Diabetologia 39:1190-1195.
15. Frittita L, Youngren J, Sbraccia P, Adamo M, Buongiorno A, Vigneri R, Goldfine I, Trischitta V (1997): Increased adipose tissue PC-1 protein content, but not TNF-alpha gene expression, is associated to a reduction of both whole body insulin sensitivity and insulin receptor tyrosine kinase activity. Diabetologia 40:282-289.
16. Funakoshi I, Kato H, Horie K, Yano Y, Kobayashi H, Inoue T, Suzuki H, Fukui S, Tsukahara M, Kajii T, Yamashina I (1992): Molecular cloning of cDNAs for human fibroblast nucleotide pyrophosphatase. Arch Biochem Biophys 295: 180-187.
17. Goldfine ID (1987): The insulin receptor: Molecular biology and transmembrane signalling. Endocr Rev 8:235-255.
18. Grupe A, Alleman J, Goldfine I, Sadick M, Stewart T (1995): Inhibition of insulin receptor phosphorylation by PC-1 is not mediated by the hydrolysis of adenosine triphosphate or the generation of adenosine. J Biol Chem 38:22085-22088.
19. Hagino H, Shii K, Yokono K, Matsuba H, Masaki Y, Hosomi Y, Okada Y, Kishimoto M, Hozumi T, Ishida Y, Kazumi T, Nishimura R, Kasuga M, Baba S (1994): Enzyme-linked immunosorbent assay method for human autophosphorylated insulin receptor applicability to insulin-resistant states. Diabetes 43:274-280.
20. Harahap A, Goding J (1988): Distribution of the murine plasma cell antigen PC-1 in non-lymphoid tissues. J Immunol 141:2317-2320.
21. Haring H, Obermaier-Kusser B (1989): Insulin receptor kinase defects in insulin-resistant tissues and their role in the pathogenesis of NIDDM. Diabetes Metab Rev 5:431-41.
22. Hawley DM, Maddux BA, Patel RG, Wong K-Y, Mamula PW, Firestone GL, Brunetti A, Verspohl E, Goldfine ID (1989): Insulin receptor monoclonal antibodies that mimic insulin action without activating tyrosine kinase. J. Biol. Chem. 264:2438-2444.
23. Hemmings B (1997): Akt signaling: Linking membrane events to life and death decisions. Science 275:628-629.
24. Hofmann C, Goldfine I, Whittaker J (1989): The metabolic and mitogenic effects of both insulin and IGF-1 are enhanced by transfection of insulin receptors into NIH3T3 fibroblasts. J Biol Chem 264:8606-8611.
25. Horie K, Yano T, Funakoshi I, Yamashina I (1989): Elevated nucleotide pyrophosphatase activity in cultured skin fibroblasts from patients with Lowe'a syndrome. Clin Chim Acta 177:41-48.
26. Jhun B, Rose D, Seely B, Rameh L, Cantley L, Saltiel A, Olefsky J (1994): Microinjection of the SH2 domain of the 85-kilodalton subunit of phosphatidylinositol-3-kinase inhibits insulin-induced DNA synthesis and c-fos expression. Mol Cell Biol 14:7466-7475.
27. Kahn C, White M (1988): The insulin receptor and the molecular mechanism of insulin action. J Clin Invest 82:1151-1156.
28. Kelly K, Ruderman N, Chen K (1992): Phosphatidylinositol-3-kinase in isolated rat adipocytes: Activation by insulin and subcellular distribution. J Biol Chem 267:3423-3428.
29. Kovacina K, Roth R (1993): Identification of SHC as a substrate of the insulin receptor kinase distinct from the GAP-associated 62 kDa tyrosine phosphorylation. Biochem Biophys Res Commun 192:1303-1311.
30. Lowry O, Rosebrough N, Farr A, Randall R (1951): Protein measurement with the Folin phenol reagent. J Biol Chem 193:285-294.
31. Maddux B, Sbraccia P, Kumakura S, Sasson S, Youngren J, Fisher A, Spencer S, Grupe A, Henzel W, Stewart T, Reaven G, Goldfine I (1995): Membrane glycoprotein PC-1 and insulin resistance in non-insulin dependent diabetes mellitus. Nature 373:448-451.
32. Maddux BA, Goldfine ID (1991): Evidence that insulin plus ATP may induce a conformational change in the beta subunit of the insulin receptor without inducing receptor autophosphorylation. J Biol Chem 266:6731-6736.
33. Moller D, Flier S (1991): Insulin resistance - Mechanisms, syndromes, and implications. N Engl J Med 325:938-948.
34. Myers M J, White M (1993): Insulin receptor substrate-1 and proteins with SH2 domains. Diabetes 42:643-650.
35. Nishimura H, Simpson I (1994): Staurosporine inhibits phorbol 12-myristate 13-acetate-and insulin-stimulated translocation of GLUT1 and GLUT4 glucose transport in rat adopose cells. Biochem J 302:271-277.
36. Olefsky J, Nolan J (1995): Insulin resistance and non-insulin dependent diabetes. Am J Clin Nutr 61:980S-986S.
37. Olefsky JM (1980): Insulin resistance and insulin action. An in vitro and in vivo perspective. Diabetes 30:148-162.
38. Pezzino V, Papa V, Trischitta V, Brunetti A, Goodman PA, Treutelaar MK, Williams JA, Maddux BA, Vigneri R, Goldfine ID (1989): Human insulin receptor radioimmunoassay: Applicability to insulin-resistant states. Am J Physiol 20:E451-E457.
39. Reaven G, Chen Y, Coulston A, Greenfield M, Hollenbeck C, Lardinois C, Liu G, Schwartz H (1983): Insulin secretion and action in non-insulin-dependent diabetes mellitus. Am J Med 75:85-93.
40. Rebbe N, Tong B, Hickman S (1993): Expression of nucleotide pyrophosphatase and alkaline phosphodiesterase I activities of PC-1, the murine plasma cell antigen. Mol Immunol 30:87-93.
41. Roberts TM (1992): A signal chain of events. Nature 360: 534-535.
42. Sanchez-Margalet V, Goldfine ID, Vlahos CJ, Sung CK (1994): Role of phosphatidylinositol-3-kinase in insulin receptor signaling: Studies with inhibitor, LY294002. Biochem Biophys Res Commun 204:446-452.
43. Sbarccia P, Goodman P, Maddux B, Chen Y-D, Reaven G, Goldfine I (1991): Production of an inhibitor of insulin receptor tyrosine kinase in fibroblasts from a patient with insulin resistance and NIDDM. Diabetes 40:295-299.
44. Seino S, Seino M, Bell G (1990): Human insulin-receptor gene. Diabetes 39:129-133.
45. Skolnik EY, Batzer A, Li N, Lee C-H, Lowenstein E, Mohammadi M, Margolis B, Schlessinger J (1993): The function of GRB2 in linking the insulin receptor to Ras signaling pathways. Science 260:1953-1955.
46. Songyang Z, Shoelson SE, Chaudhuri M, Gish G, Pawson T, Haser WG, King F, Roberts T, Ratnofsky S, Lechleider RJ, Neel BG, Birge RB, Fajardo JE, Chou MM, Hanafusa H, Schaffhausen B, Cantley LC (1993): SH2 domains recognize specific phosphopeptide sequences. Cell 72:767-778.
47. Sung C, Sanchez-Margalet V, Goldfine I (1994): Role of p85 subunit of phosphatidylinositol-3-kinase as an adaptor molecule linking the insulin receptor, p62 and GTPase activating protein. J Biol Chem 269:12503-12507.
48. Sung CK Goldfine ID (1992): Phosphatidylinositol-3-kinase is a non-tyrosine phosphorylated member of the insulin receptor signalling complex. Biochem Biophys Res Commun 189:1024-1030.
49. Sung CK, Maddux BA, Hawley DM, Goldfine ID (1989): Monoclonal antibodies mimic insulin activation of ribosomal protein S6 kinase without activation of insulin receptor tyrosine kinase. J Biol Chem 264:18951-18959.
50. Taylor S, Kadowaki T, Kodowaki H, Accili D, Cama A, McKeon C (1990): Mutations in insulin-receptor gene in insulin-resistant patients. Diabetes Care 13:257.
51. White M, Kahn CR (1994): The insulin signaling system. J Biol Chem 269:1-4.
52. Yamamoto-Honda R, Tobe K, Kaburagi Y, Uek, K, Asai S, Yachi M, Shirouzu M, Yodoi J, Akanuma Y, Yokoyama S, Yazaki Y, Kadowaki T (1995): Upstream mechanisms of glycogen synthase activation by insulin and insulin-like growth factor-I. J Biol Chem 270:2729-2734.
53. Yang J, Holman GD (1993): Comparison of GLUT4 and GLUT1 subcellular trafficking in basal and insulin-stimulated 3T3-L1 cells. J Biol Chem 268:4600-4603.
54. Yang J, Holman G, Kasuga M, Young P, Ester C, Clarke J (1996): Phosphatidylinositon-3-kinase acts at an intracellular membrane site to enhance GLUT4 exocytosis in 3T3-L1 cells. Biochem J 313:125-131.
55. Yarden Y, Ullrich A (1988): Growth factor receptor tyrosine kinase. Annu Rev Biochem 57:443-478.
56. Youngren J, Maddux B, Sasson S, Sbraccia P, Tapscott E, Swanson M, Dohm G, Goldfine I 1996): Skeletal muscle content of membrane glycoprotein PC-1 in obesity. Diabetes 45:1324-1328.
57. Zasloff M, Ochoo S 1992): Methods in Enzymology 200:197-201.